During the past six years. we have treated eight patients with cystic
fibrosis (CF) for nephrolithiasis. In seven patients, the stones were
comprised of calcium oxalate. Another six patients had calcium oxalate
crystalluria. In our CF population of 140 patients, this represents a
cumulative incidence of calcium oxalate nephrolithiasis of 5.7 percen
t and an additional 4.2 percent incidence of crystalluria. Experience
with these patients is reviewed. Pancreatic insufficiency was universa
lly associated with nephrolithiasis or crystalluria. Diabetes and cirr
hosis were also common. Predisposing factors and potential mechanisms
of stone disease in pancreatic insufficient CF patients are discussed,
focusing on the relationship between fat malabsorption in CF to oxala
te metabolism.